Inhibition of polysome assembly enhances imatinib activity against chronic myelogenous leukemia and overcomes imatinib resistance
10.1128/MCB.00477-08
Saved in:
Main Authors: | Zhang, M., Fu, W., Prabhu, S., Moore, J.C., Ko, J., Kim, J.W., Druker, B.J., Trapp, V., Fruehauf, J., Gram, H., Fan, H.Y., Ong, S.T. |
---|---|
Other Authors: | DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE |
Format: | Article |
Published: |
2016
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/132485 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Adverse effects of imatinib in children with chronic myelogenous leukemia
by: Choeyprasert W., et al.
Published: (2017) -
Adverse effects of imatinib in children with chronic myelogenous leukemia
by: Worawut Choeyprasert, et al.
Published: (2018) -
Adverse effects of imatinib in children with chronic myelogenous leukemia
by: Worawut Choeyprasert, et al.
Published: (2018) -
Impact of molecular response time achievement on survival of chronic phase chronic myelogenous leukemia patients treated by imatinib
by: Putu Niken Ayu Amrita, et al.
Published: (2020) -
Overcoming imatinib resistance conferred by the BIM deletion polymorphism in chronic myeloid leukemia with splice-switching antisense oligonucleotides
by: Liu, J, et al.
Published: (2020)